Enthera Pharmaceuticals
ItalyEntry
2022
Hold
4yr
Status
Active
Who owns Enthera Pharmaceuticals?
Enthera Pharmaceuticals is currently owned by Sofinnova Partners through Sofinnova Capital X (2021 vintage), since 2022.
Hand-verified · updated 2026-04-21
More from Sofinnova Capital X
Other portfolio companies in the same fund.
Germany
Denmark
France
Spain
UK
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Enthera Pharmaceuticals
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Enthera Pharmaceuticals?
0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Enthera Pharmaceuticals.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue